Acousia Therapeutics

Developer of small molecule therapeutics supporting cellular regeneration to reverse hearing loss

placeTubingen, Baden Wurttemberg, Germany calendar_todayFounded 2012 groups4 employees language acousia.com

Registered entities

Innovation

5 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 199 times.

YearFilings
20151
20161
20171
20181
20191
20201
20211
20222
20232
20243
20253
20263

Social engagement

Social engagement: 562 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Esperante, Creathor Venture, LBBW Venture Capital.

Investor typeCountShare
Venture capital457%
Other / undisclosed343%

Recent activity

17 Jun 2026
Partnership
BIO International
14 Nov 2025
Event
London Life Sciences Week
2 Oct 2025
Event
BioJapan
Coming soon